Analysts Bet Celebrex Won't Be Withdrawn
196262
Some analysts are betting Pfizer Inc.  won't have to withdraw its arthritis drug Celebrex but they do  expect sales to fall after a study of the drug in cancer  patients showed it increased the risk of heart attacks.
224987
Doctors should limit use of Pfizer Inc.&#39;s Celebrex and Bextra pain drugs while regulators continue to weigh their cardiovascular risks, the US Food and Drug Administration said.
108249
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis, despite a disclosure last week that the drug had increased
119087
Pfizer Inc. says it will immediately pull advertising for its top-selling arthritis pain reliever Celebrex, whose safety was called into question last week after a study found an increased risk of heart attacks in patients taking high dosages of the drug.
483616
Pfizer Inc. may fall short in convincing federal regulators that its painkiller Celebrex should receive expanded approval to treat children with a devastating form of arthritis, according to documents released Tuesday.
484469
Pfizer Inc. shares rebounded on  Tuesday as a study of Alzheimer's patients found that its  arthritis drug Celebrex carried no increased cardiovascular  risks, differing from findings of a study in cancer patients  released last week.
652619
Bad press from Vioxx shouldn't overshadow the company's new offering.
181327
When Merck withdrew Vioxx from the market in late September, many patients and their doctors turned to Celebrex with relief, counting on it to deal with
478882
Pfizer (PFE) said Friday that is has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial.
546632
New prescriptions for Pfizer Inc.'s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, the Wall Street Journal said.
177782
A U.S. consumer group on Monday accused Pfizer Inc. of burying a study suggesting its painkiller Celebrex boosts the risk of heart attack and stroke, a claim the No. 1 drug maker has denied.
482981
NEW YORK - Pfizer Inc. said it found an increased risk of heart attacks for patients taking high dosages of its top-selling painkiller Celebrex, the same problem that led to the withdrawal of its one-time competitor Vioxx.
165835
Celebrex continues to sell, while Vioxx got yanked. Courts, doctors, patients, and investors will decide which approach is better.
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
573622
FRIDAY, Oct. 8 (HealthDayNews) -- A week after drug giant Merck & Co. withdrew its arthritis drug Vioxx from the market, doubts are being raised about the safety of the two other approved medications in this class, Bextra and Celebrex.
614229
Even if regulators do not force Pfizer to withdraw Celebrex, its prospects are dim if doctors stop prescribing it in the volume they have in recent years.
169285
A study of the arthritis drug Celebrex made more than four years ago by Pfizer Inc. casts doubt on the company's insistence that it had no hint of the drug's potential heart and stroke risks until recently.-The Washington Post